Literature DB >> 9691231

Schild regression analysis of antidepressant and bicuculline antagonist effects at the GABAA receptor.

E Malatynska1, G Crites, A Yochum, R Kopp, M L Giroux, S C Dilsaver.   

Abstract

We showed previously that antidepressants inhibit GABA-stimulated 36Cl- uptake in rat cerebral cortex. In this study Schild analysis was used to determine if antidepressants are competitive antagonists or allosteric modulators at GABAA receptors. GABA concentration-response curves for 36Cl- uptake in rat cerebral cortex were generated in the absence or presence of different concentrations of the following antidepressants: amitriptyline, amoxapine, mianserin, and also the GABAA receptor antagonist, bicuculline. The pA2 values for amitriptyline, amoxapine, mianserin, and bicuculline were 4.2 +/- 0.2, 5.5 +/- 0.3, 4.4 +/- 0.1 and 6.2 +/- 0.6, respectively. The respective Schild slope values were 0.7 +/- 0.1, 0.6 +/- 0.03, 0.7 +/- 0.2 and 1.0 +/- 0.3. All slope values for antidepressants differed from unity. The maximum effect produced by GABA to stimulate chloride influx was decreased by both antidepressants and bicuculline. It is concluded that neither the antidepressants studied nor bicuculline are pure competitive GABA antagonists at the GABAA receptor-chloride-ionophore complex in the rat cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9691231     DOI: 10.1159/000028232

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  5 in total

1.  The GABA(A) receptor complex as a target for fluoxetine action.

Authors:  G Tunnicliff; N L Schindler; G J Crites; R Goldenberg; A Yochum; E Malatynska
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

2.  Characterization of the interaction between anthrax toxin and its cellular receptors.

Authors:  Shihui Liu; Howard J Leung; Stephen H Leppla
Journal:  Cell Microbiol       Date:  2007-04       Impact factor: 3.715

3.  Intermolecular complementation achieves high-specificity tumor targeting by anthrax toxin.

Authors:  Shihui Liu; Vivien Redeye; Jeffrey G Kuremsky; Marissa Kuhnen; Alfredo Molinolo; Thomas H Bugge; Stephen H Leppla
Journal:  Nat Biotechnol       Date:  2005-05-15       Impact factor: 54.908

Review 4.  Central GABAergic systems and depressive illness.

Authors:  G Tunnicliff; E Malatynska
Journal:  Neurochem Res       Date:  2003-06       Impact factor: 3.996

5.  Role of N-terminal amino acids in the potency of anthrax lethal factor.

Authors:  Pradeep K Gupta; Mahtab Moayeri; Devorah Crown; Rasem J Fattah; Stephen H Leppla
Journal:  PLoS One       Date:  2008-09-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.